Riad Sherif
Net worth: 24 M $ as of 31/05/2026
Net worth: 24 M $ as of 31/05/2026
Dr. Riad Sherif is an Independent Director at Revenio Group Oyj, a Chief Executive Officer & Director at Oculis Holding AG, a Chief Executive Officer & Director at Oculis SA, a Chairman at XPND Medical SA and a Chairman at Nexmed Plus SA. He is on the Board of Directors at Revenio Group Oyj, Oculis Holding AG and Oculis SA. Dr. Sherif was previously employed as a President-Europe, Middle East & Africa by Alcon AG, a Global Head-Sales by Novartis AG, a President & CEO-EMEA region by Alcon Finland OY, a Chairman-Board Ophthalmic Surgery & Vision Care by European Medical Device Industry Association, a Vice Chairman by Innovative Medicines Canada, a President-Latin America Region by Novartis Corp., a President by Novartis Pharmaceuticals Canada, Inc., a Country Manager by Sanofi-Aventis Algérie SpA, and a Co-Founder by Synergium UAB. He also served on the board at European Biotech Acquisition Corp.
He received his graduate degree from ESCP Business School and an MBA from the International Institute for Management Development.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OCULIS HOLDING AG 1.87% | 31/12/2025 | 1,066,287 ( 1.87% ) | 24 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| REVENIO GROUP OYJ | Director/Board Member | 08/04/2022 |
| OCULIS HOLDING AG | Chief Executive Officer | 01/12/2017 |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Chief Executive Officer | 01/01/2017 |
XPND Medical SA
XPND Medical SA Miscellaneous Commercial ServicesCommercial Services Operates as a consulting firm helping clients in the pharmaceutical and med-tech industries | Founder | 01/01/2016 |
| Companies | Position | End |
|---|---|---|
| ALCON, INC. | Corporate Officer/Principal | 01/05/2016 |
| NOVARTIS AG | Sales & Marketing | 01/04/2014 |
Alcon Finland OY | Corporate Officer/Principal | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | - |
Sanofi-Aventis Algérie SpA
Sanofi-Aventis Algérie SpA Pharmaceuticals: MajorHealth Technology Operates pharmaceutical production plant | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 16 |
|---|---|
Alcon AG
Alcon AG Medical SpecialtiesHealth Technology Develops, manufactures and distributes surgical & eye care devices | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Revenio Group Oyj
Revenio Group Oyj Medical SpecialtiesHealth Technology Develops, manufactures and sells tonometers | Health Technology |
International Institute for Management Development
International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
European Medical Device Industry Association | |
Alcon Finland OY | |
Sanofi-Aventis Algérie SpA
Sanofi-Aventis Algérie SpA Pharmaceuticals: MajorHealth Technology Operates pharmaceutical production plant | Health Technology |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines and vaccines | Commercial Services |
Synergium UAB
Synergium UAB Miscellaneous Commercial ServicesCommercial Services Provides language translation services | Commercial Services |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Commercial Services |
European Biotech Acquisition Corp.
European Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Escp Business School
Escp Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oculis Holding AG
Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
XPND Medical SA
XPND Medical SA Miscellaneous Commercial ServicesCommercial Services Operates as a consulting firm helping clients in the pharmaceutical and med-tech industries | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions